Subscribe to Supplier

Subscribe to Supplier

.
ARTES successfully completes EU-funded project PLURIVAX

ARTES Biotechnology GmbH News Releases

Find the latest News from ARTES Biotechnology GmbH

Page 3 of 4
ARTES successfully completes EU-funded project PLURIVAX
ARTES successfully completes EU-funded project PLURIVAX Learn More >
ARTES presenting protein production and vaccine development opportunities at BIO-Europe 2018
ARTES presenting protein production and vaccine development opportunities at BIO-Europe 2018 Learn More >
ARTES brings new vaccine advances to veterinary ‘Dragons’ Den’
ARTES brings new vaccine advances to veterinary ‘Dragons’ Den’ Learn More >
ARTES seeking new collaborations at BioFIT 2017
ARTES seeking new collaborations at BioFIT 2017 Learn More >
ARTES receives French CIR Research Tax Credit Accreditation
ARTES receives French CIR Research Tax Credit Accreditation Learn More >
EU patent grant for ARTES Biotechnology METAVAX®
EU patent grant for ARTES Biotechnology METAVAX® Learn More >
ARTES enters Animal Health Investment Dragons Den
ARTES enters Animal Health Investment Dragons Den Learn More >
ARTES in co-development deal for HPV vaccine
ARTES in co-development deal for HPV vaccine Learn More >
ARTES in partnership to develop novel hepatitis C vaccine
ARTES in partnership to develop novel hepatitis C vaccine Learn More >
ARTES Biotechnology joins forces with Italy’s Biosphere
ARTES Biotechnology joins forces with Italy’s Biosphere Learn More >
ARTES fast tracks new plant to manufacture multi-gram preclinical samples
ARTES fast tracks new plant to manufacture multi-gram preclinical samples Learn More >
ARTES to exhibit at DBT 2015 Cologne
ARTES to exhibit at DBT 2015 Cologne Learn More >
Page 3 of 4